Herpetic esophagitis following bendamustine-containing regimen

Herpetic esophagitis: a diagnostic challenge in immunocompromised patients.

Viral esophageal infection is common in immunocompromised patients. Twelve patients with esophagitis secondary to herpes viruses are described. Odynophagia, dysphagia, and gastrointestinal bleeding were the most common symptoms. Multiple infections particularly with candida were present in three of the 12 cases (25%). Typical "volcano ulcers" at endoscopy and discrete diffusely scattered shallo...

Eosinophilic esophagitis and herpetic esophagitis: cause or consequence?

Association between eosinophilic esophagitis and herpetic esophagitis has been suggested in some studies but it continues been so controversial. We present two clinical cases of two immunocompetent patients who did not have any previous predisposing treatment and who present both diseases; that is the reason we suggest that they may have any relation.

Acute Herpetic Esophagitis

Herpetic Esophagitis in Immunocompetent Medical Student

Esophagitis caused by herpes simplex virus (HSV) is often documented during periods of immunosuppression in patients infected with human immunodeficiency virus (HIV); it is rare in immunocompetent diagnosed patients. Case reports of herpetic esophagitis in students of health sciences are extremely rare. The disease presents with a clinical picture characterized by acute odynophagia and retroste...

Optimizing premedications in the prevention of bendamustine infusion-related reactions.

BACKGROUND Bendamustine is indicated for the treatment of chronic lymphocytic leukemia (CLL) and rituximab refractory indolent non-Hodgkin lymphoma. Clinical trials have reported a 25% incidence of infusion-related reactions (IRRs) in patients receiving bendamustine. While these reactions are well documented, there is no consensus on the optimal premedication regimen for the prevention of these...